ARPKD is commonly attributed to genetic variants in the fibrocystin gene polycystic kidney and hepatic disease 1 (PKHD1, OMIM 606702) and the presence of at least one truncating variant is predictive of perinatal lethality [1]. This evidence concerns the gene PKHD1 and urogenital neoplasm.